Tag: Genome


Groupon ‘done’ deals 240,000 in Q2

Groupon ‘done’ deals 240,000 in Q2

While still struggling financially as of Q2 2014, Groupon's (NASDAQ: GRPN) transition to mobile-focused  push marketplace is resulting in more consumers buying more deals for more money. Gross billings increased 29 percent to $1.82 billion, and revenue increased 23 percent to $752 million.  In Q2 Groupon complet

This post is only available to members.